Differential effect of caffeine intake in subjects with genetic susceptibility to Parkinson's Disease

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Kumar, Prakash M ^a,b   Paing, Swe Swe Thet ^a,b   Li, Huihua ^c   Pavanni, R ^a,b   Yuen, Y ^c   Zhao, Y ^b   Tan, Eng King ^a,b  

^a DUKE NUS MEDICAL SCHOOL   (Singapore)

^b NATIONAL NEUROSCIENCE INSTITUTE   (Singapore)

^c SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE;

ADULT; AGED; CASE CONTROL STUDY; DRINKING; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETIC VARIATION; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; PARKINSON DISEASE; RISK; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CAFFEINE; CASE-CONTROL STUDIES; DRINKING; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; RISK; YOUNG ADULT;

EID: 84946057538     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep15492     Document Type: Article

References (10)

1. Tan, E. K., Skipper, L. M. Pathogenic Mutations in Parkinson Disease. Hum Mutat 28, 641-53 (2007).
2. Zimprich, A. et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44, 601-7 (2004).
3. Tan, E. K. et al. Multiple LRRK2 Variants Modulate Risk of Parkinson Disease: A Chinese Multicenter Study. Hum Mutat 31, 561-8 (2010).
4. Ross, O. A. et al. Analysis of LRRK2 R1628P as a risk factor for Parkinson's Disease. Annals of Neurology 64, 88-96 (2008).
5. Costa, J., Lunet, N., Santos, C., Santos, J., Vaz-Carneiro, A. Caffeine exposure and the risk of Parkinson's disease: a systematic review and meta-analysis of observational studies. Journal of Alzheimer's disease 20, S221-38 (2010).
6. Tan, E. K., Tan, C., Fook-Chong, S. et al. Dose-dependent protective effect of coffee, tea, and smoking in Parkinson's disease: a study in ethnic Chinese. Journal of Neurological Sciences 216, 163-7 (2003).
7. Chan, S. L., Angeles, D. C., Tan, E. K. Targeting leucine-rich repeat kinase 2 in Parkinson's disease. Expert Opin Ther Targets. 17, 1471-82 (2013)
8. Saiki, S., Sato, S., Hattori, N. Molecular pathogenesis of Parkinson's disease: update. J. Neurol Neurosurg Psychiatry. 83, 430-6 (2012).
9. Buhat, D. M., Tan, E. K. Genetic testing of LRRK2 in Parkinson's disease: is there a clinical role? Parkinsonism Relat Disord. 20, S54-6 (2014).
10. Yip, C. W., Tan, E. K. Test-retest repeatability of assessing environmental and lifestyle factors in Parkinson's disease. Mov Disord. 23, 1032-6 (2008)